Personalis Current Ratio 2018-2024 | PSNL
Personalis current ratio from 2018 to 2024. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
| Personalis Current Ratio Historical Data |
| Date |
Current Assets |
Current Liabilities |
Current Ratio |
| 2024-09-30 |
$0.17B |
$0.04B |
4.68 |
| 2024-06-30 |
$0.11B |
$0.03B |
3.31 |
| 2024-03-31 |
$0.12B |
$0.03B |
3.84 |
| 2023-12-31 |
$0.15B |
$0.05B |
3.11 |
| 2023-09-30 |
$0.15B |
$0.03B |
4.56 |
| 2023-06-30 |
$0.16B |
$0.03B |
5.63 |
| 2023-03-31 |
$0.18B |
$0.03B |
5.35 |
| 2022-12-31 |
$0.20B |
$0.03B |
6.03 |
| 2022-09-30 |
$0.22B |
$0.03B |
6.58 |
| 2022-06-30 |
$0.26B |
$0.04B |
6.27 |
| 2022-03-31 |
$0.29B |
$0.04B |
7.38 |
| 2021-12-31 |
$0.32B |
$0.03B |
10.16 |
| 2021-09-30 |
$0.33B |
$0.03B |
12.41 |
| 2021-06-30 |
$0.35B |
$0.03B |
10.39 |
| 2021-03-31 |
$0.37B |
$0.04B |
9.66 |
| 2020-12-31 |
$0.22B |
$0.04B |
5.43 |
| 2020-09-30 |
$0.22B |
$0.04B |
6.23 |
| 2020-06-30 |
$0.12B |
$0.04B |
2.79 |
| 2020-03-31 |
$0.14B |
$0.05B |
2.60 |
| 2019-12-31 |
$0.14B |
$0.05B |
2.79 |
| 2019-09-30 |
$0.14B |
$0.05B |
2.96 |
| 2019-06-30 |
$0.18B |
$0.06B |
3.13 |
| 2019-03-31 |
$0.00B |
|
0.00 |
| 2018-12-31 |
$0.00B |
|
0.00 |
| 2018-09-30 |
$0.00B |
|
0.00 |
| 2018-06-30 |
$0.00B |
|
0.00 |
| 2017-12-31 |
$0.00B |
|
0.00 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$0.261B |
$0.073B |
|
Personalis Inc. is a cancer genomics company. It is engaged in the development of therapies by providing molecular data about each patient's cancer and immune response. Personalis Inc. is based in Menlo Park, California.
|
